Forget Password Form

AbbVie Site Generator

false

decorative

AQUIPTA is a prescription medicine, available as tablets containing 60 mg of atogepant. It is used to prevent migraine in patients who have at least 4 migraine days per month.1

Do not use AQUIPTA if you have ever had an allergic reaction to atogepant or any of the ingredients.1

Before you use AQUIPTA, tell your doctor if you have: allergies to any medicines, foods, preservatives or dyes; have any liver or kidney problems; take any medicines for any other condition; are pregnant or plan on becoming pregnant; or are breastfeeding or plan to breastfeed.1

Tell your doctor straight away if you become pregnant while taking AQUIPTA or if you experience any symptoms of an allergic reaction, such as difficulty breathing, swelling of face, itching, rash, or hives.1

Go straight to the Emergency Department of your nearest hospital if you notice any signs of serious allergic reaction, including difficulty breathing, swelling of the face, itching, red rash or hives.1

Tell your doctor and other health care professionals if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may affect how AQUIPTA works or may increase the risk of getting side effects.1

Common side effects: Tell your doctor if you experience any side effects that make you feel unwell. Common side effects of AQUIPTA include decreased appetite, nausea, constipation, drowsiness (sleepiness) and tiredness.1

If you have any questions about using AQUIPTA, including its risks and benefits, how much to use, how and when to use it, or the storage conditions, consult your healthcare professional and refer to the Consumer Medicine Information available from abbv.ie/nz-aqui-cmi or freephone 0800 900 030.

Ask your doctor if AQUIPTA is right for you. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or healthcare professional.

AQUIPTA is an unfunded medicine. It is available for private purchase, which means you will need to pay for this medicine. Normal pharmacy and doctor’s charges apply.

Reference: 1. AQUIPTA® (atogepant) Consumer Medicine Information.

The content on this site is intended solely for New Zealand residents. It is intended for informational purposes only and should not be used to replace a discussion with a healthcare professional. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient.

This website is developed and produced by AbbVie Ltd. AbbVie is the company that brings you AQUIPTA®. For more information about AbbVie, visit www.AbbVie.co.nz.

LegitScript

AbbVie Limited, 6th floor, 156-158 Victoria Street, Wellington, 6011, New Zealand 0800 900 030. AQUIPTA® is a registered trademark of Allergan Sales LLC. NZ-AQP-240022. BG5806. April 2026. Copyright © AbbVie Limited.

AbbVie Logo

Leaving Site

You are about to leave this website. General disclaimer: The information you are about to be referred to may not comply with the New Zealand regulatory requirements. Further information relevant to the New Zealand environment is available from the company or via the Data Sheet. The intent of providing this link is to inform and not to offer advice. AbbVie is not responsible for the content of the website you are entering.

Do you wish to continue?

No
Yes
  • https://www.medsafe.govt.nz/
  • https://www.abbvie.co.nz/
  • https://www.migrainetreatment.co.nz/